Industry Research Reports and Market Analysis at MindBranch.com Research Index | Publishers | My Account | Contact Us | About MindBranch
Welcome Guest  (Login/Register) |  0 items
  
Advanced Search > | Tips >
Contact a
Research Assistant

US 800-774-4410
or +1-240-747-3094

Search Assistance >

Home  > Healthcare  >  Pharmaceutical  >  General Pharmaceutical

Chattem, Inc. and the U.S. Pharmaceutical Preparation Manufacturing Industry


Published Date: November 2008
Published By: Supplier Relations US, LLC
Page Count: 92
Order Code: R3418-4129
 
DescriptionTable of ContentsSimilar
Products

The Chattem, Inc. company report details the company's key financial data, business operations, technology and patent activities, financial benchmarks against the Pharmaceutical Preparation Manufacturing industry in the US, and that industry's pertinent information such as financial data, downstream industries, competitive landscape, upstream industries, and industry structure.

This company report provides a breadth of information on the company and its relevant industry in the US - Pharmaceutical Preparation Manufacturing industry, represented by the 6-digit NAICS code 325412. The report first presents the company data, and then presents industry data in a similar, logical flow for the reader to draw relevant comparisons. The complete understanding of the company and its industry allow for better forecasting of specific and industry-wide trends in times of economic uncertainty. This detailed information resource contains at least 5 years of independently researched industry statistics cross-referenced with the relevant U.S. and international economic indicators. All data have been verified to ensure the highest quality.

In this report, you will find company and industry data on the following major categories:

Executive Summary

  • High level summary of the company and the relevant industry

  • Revenue numbers for the past 3 years

Company Overview

  • The company's operations, businesses, and products

  • Employees, officers, locations (when relevant)

Company Financial Summary

  • Yearly income statement, sales by segment, balance sheet, cash flow statement

  • Financial ratios - calculations and detailed explanations

  • Executive compensation summary

Company Patents and Technology

  • US Patent and Trademark Office (USPTO) patent holdings and applications

  • Patent classification listing for analyzing research and development trends

U.S. Industry and Comparison

  • Industry financials from income statement to balance sheet

  • Income statement benchmarks - Company against Industry

Industry Information

  • Product market sizes - percentage of sales of each product category within the industry

  • Pricing Distribution among Downstream Industries differentiated at producer, wholesale, retail, and freight categories

  • Industry Concentration: HHI, number of companies, size distributions, top level market shares

  • Major Players: company profiles and market size ranges

  • Cost analysis: Materials and their percentage share of total material costs

  • Upstream Industries and the cost allocations towards producer, wholesale, retail, and freight

  • Labor and Compensation Structure: productivity indices, hourly wages, production hours, output index, HR structure

  • Establishments: Trends, Employee Statistics, State by State numbers

Relevant References

  • Complete list of the company's subsidiaries

  • Industry trade associations and publications

  • Industry 4-year financial statement

Company Revenue Preview

Chattem, Inc. generated $423M, $300M, and $279M worth of revenue in the fiscal years ending approximately November 30, 2007, 2006, and 2005. In those respective years, the company's gross profit margins were 69.5%, 68.7%, and 71.4%.

Excel Datasheet

The data presented in the report is also included in an Excel file for further analysis and data manipulation. It includes all of the company's financial data presented in the report (income statement, balance sheet, cash flow statement, segment data, financial ratios), executive compensation, subsidiary listing, USPTO patent activities (dates, application numbers, abstracts), and links to SEC filings. This valuable resource provides the freedom and convenience to conduct further research into the company at your will, be it data-mining or integration into forecast models.

Report Summary

This 92-page research report provides an unparalleled breadth and diversity of information on Chattem, Inc. and its relevant industry. The two-part presentation of data, company and industry, paints the most complete picture of the company and its business. The summary of the company's operations and structure, backed up by crucial financial numbers, allows one to quickly understand the company. And the inclusion of hard-to-find data such as sales by segment, patent activities, subsidiary listings, and executive compensation further enhance this research.

The industry data, with a macroeconomic perspective, provides the indispensable context of the arena in which the company operates. This unique insight is provided by the enclosed sections covering the industry. In the cost analysis section, 52 upstream industries are analyzed to offer insight into the supply chain cost structure. For the channel and pricing structure, 31 downstream industries are analyzed. The competitive landscape section provides the number of companies and their revenue share within the industry, the market concentration, and a list of major players. All related trade associations, industry standards, and trade publications are also listed.

Our clients include Fortune 500 companies, manufacturers, international top consulting firms, major retailers and wholesalers, professional trade associations, financial corporations, universities, governmental entities, start-ups and individuals. We are committed to providing the highest level of quality to all our clients and assure your satisfaction in the report delivering as promised.

Please note: This is delivered as a Zip file.

Similar Products
SensiGen, LLC. Product Pipeline Analysis
Published Jan 2009 by Global Markets Direct


GUIDED THERAPEUTICS, INC. Product Pipeline Analysis
Published Jan 2009 by Global Markets Direct


Kuros Biosurgery AG Product Pipeline Analysis
Published Jan 2009 by Global Markets Direct


A&G Pharmaceutical, Inc. Product Pipeline Analysis
Published Jan 2009 by Global Markets Direct


Sequella, Inc. Product Pipeline Analysis
Published Jan 2009 by Global Markets Direct


Interface Biologics, Inc. Product Pipeline Analysis
Published Jan 2009 by Global Markets Direct


China Sky One Medical, Inc. Product Pipeline Analysis
Published Jan 2009 by Global Markets Direct


Innocoll Technologies Ltd Product Pipeline Analysis
Published Jan 2009 by Global Markets Direct


Endovasc, Inc. Product Pipeline Analysis
Published Jan 2009 by Global Markets Direct


Chembio Diagnostic Systems, Inc. Product Pipeline Analysis
Published Jan 2009 by Global Markets Direct




 


Privacy Policy | Terms & Conditions | Site Map | Return Policy | Help FAQs
Copyright © 1999-2008, All Rights Reserved, MindBranch.com
Trust-e Logo
Phone: 800-774-4410 (US) or +1-240-747-3094 (Int'l)
Hours: 7:00 a.m. to 7:00 p.m. EST Monday through Friday
Email: support@mindbranch.com